A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Osteoporosis International

• Publication date

  2018-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00198-017-4340-5PMID 29260291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates

  2017cited by this paper
• EULAR/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures

  2016cited by this paper
• Increased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fracture

  2016cited by this paper
• Meeting international standards of secondary fracture prevention: a survey on Fracture Liaison Services in the Netherlands

  2015cited by this paper
• Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture® Best Practice Framework tool

  2015cited by this paper
• Richtlijn Osteoporose en fractuurpreventie

  2015cited by this paper
• Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study

  2015cited by this paper
• Long-term persistence with anti-osteoporosis drugs after fracture

  2015cited by this paper
• Improving adherence to and persistence with oral therapy of osteoporosis

  2015cited by this paper
• Fracture liaison service: impact on subsequent nonvertebral fracture incidence and mortality.

  2014cited by this paper
• Characteristics of Bone Turnover in the Long Bone Metaphysis Fractured Patients with Normal or Low Bone Mineral Density (BMD)

  2014cited by this paper
• Proactive pharmaceutical care interventions decrease patients’ nonadherence to osteoporosis medication

  2014cited by this paper
• Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist management

  2014cited by this paper
• Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis

  2013cited by this paper
• Detecting outliers: Do not use standard deviation around the mean, use absolute deviation around the median

  2013cited by this paper
• Best Practices in Secondary Fracture Prevention: Fracture Liaison Services

  2013cited by this paper
• Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group

  2013cited by this paper
• Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle

  2013cited by this paper
• Osteoporosis in the European Union: a compendium of country-specific reports

  2013cited by this paper
• Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention

  2012cited by this paper
• Impact of a Phone Follow-Up Program on Persistence with Teriparatide or PTH(1–84) Treatment

  2012cited by this paper
• Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial.

  2012cited by this paper
• Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards

  2011cited by this paper
• Coordinator-based systems for secondary prevention in fragility fracture patients

  2011cited by this paper
• Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice

  2011cited by this paper
• The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis

  2010cited by this paper
• Adherence and profile of non-persistence in patients treated for osteoporosis—a large-scale, long-term retrospective study in The Netherlands

  2010cited by this paper
• A telephone-based intervention for increasing the use of osteoporosis medication: a randomized controlled trial.

  2009cited by this paper
• Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review

  2009cited by this paper
• Adherence to osteoporosis medications after patient and physician brief education: post hoc analysis of a randomized controlled trial.

  2009cited by this paper
• Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis.

  2007cited by this paper
• Effect of Fracture on Bone Turnover Markers: A Longitudinal Study Comparing Marker Levels Before and After Injury in 113 Elderly Women

  2007cited by this paper
• Telephone Counseling to Improve Osteoporosis Treatment Adherence: An Effectiveness Study in Community Practice Settings

  2007cited by this paper
• Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study

  2006cited by this paper
• Education and Phone Follow-Up in Postmenopausal Women at Risk for Osteoporosis

  2005cited by this paper
• The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial.

  2004cited by this paper
• Adherence to Long-Term Therapies: Evidence for Action

  2003cited by this paper
• Vertebral fracture assessment using a semiquantitative technique

  1993cited by this paper

• Return on investment of fracture liaison services: a systematic review and analysis

  2024cites this paper
• A quasi-experimental study about shared decision-making and motivational interviewing on patients with a recent fracture attending Fracture Liaison Services

  2024cites this paper
• Supporting patients to get the best from their osteoporosis treatment: a rapid realist review of what works, for whom, and in what circumstance

  2022cites this paper
• Single pharmacy governed denosumab home administration: optimal adherence by means of a fracture liaison service (FLS) and home care collaboration

  2021cites this paper
• Condition still critical: compliance and persistence with osteoporosis medications

  2021cites this paper
• Extent of and reasons for osteoporosis medication non-adherence among veterans and feasibility of a pilot text message reminder intervention

  2021cites this paper
• Osteoporosis care amidst the prolonged pandemic

  2021cites this paper
• Patients discharged from a fracture liaison service still require follow-up and bone health advice

  2020cites this paper
• Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review

  2020influential citation
• Patients’ reasons for adhering to long-term alendronate therapy

  2019cites this paper